Ayala Pharmaceuticals, Inc. ADXS
0.60 USD 0.00 (+0.00%)
At closeFeb 4, 2026, 4:00 PM EST
0.0846 Day range 0.60355
0.121 52-week range 1.57
- YTD
- +1,405.11%
- 1 year
- +2,014.01%
Analyst view
Consensus: buy
Buy
Price target (mean) —
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 1
- 2 months ago 1
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.10 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 2.99M | +1081.8% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2020 | H.C. Wainwright | Downgrade | Buy | Neutral |
| Nov 25, 2020 | Jefferies | Downgrade | Buy | Hold |
| Nov 25, 2020 | H.C. Wainwright | Maintained | Buy | Buy |
| Nov 25, 2020 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Nov 25, 2020 | Barclays | Maintained | — | Overweight |
| Nov 25, 2020 | Barclays | Maintained | — | Overweight |
| Nov 25, 2020 | Barclays | Initiated | — | Overweight |
| Nov 25, 2020 | H.C. Wainwright | Maintained | — | Buy |
| Nov 25, 2020 | Jefferies | Initiated | — | Buy |
| Nov 25, 2020 | Janney Capital | Initiated | — | Buy |
| Nov 25, 2020 | MLV & Co. | Initiated | — | Buy |